Roberto Lara

Coffee, Science, Global Drug Development | #PrecisionMedicine | #Oncology #CellandGeneTherapy | Father to 3 daughters | Husband to exceptional wife | #GoHabsGo

[Roberto Lara @RL_OncoDrugDev]

@ChrisDoko Hi Chris I hope all is well. Have you by any chance published any data on average first year launch revenue and average peak revenues by therapeutic area? I recall seeing an article on @endpts on the topic but wasnt sure if it was from you?

[Roberto Lara @RL_OncoDrugDev]

@EricTopol any RWE updates on COMIRNATY in 5-11 y/o.

[Roberto Lara @RL_OncoDrugDev]

@PTarantinoMD Looks awesome and reminds me of Neptune Oyster’s lobster roll! My fav

[Roberto Lara @RL_OncoDrugDev]

@michael_gilman Roy Damphousse and Carbo on mine. #Habs shake up

[Sportsnet @Sportsnet]

Once hockey's most sought-after coach, has Mike Babcock learned anything after his fall from grace?

BIG READ 📚 | ✍️: @ByDavidSingh

https://t.co/y1ejHMQAIS

[Roberto Lara @RL_OncoDrugDev]

CDER Pilot Program Offers Potential New Pathway For Approval Of Novel Pharmaceutical Excipients https://t.co/uRoXkec3lb

[Roberto Lara @RL_OncoDrugDev]

Sharp Increase in Cancer Incidence and Mortality From 2020-2040 https://t.co/i8FOGIwqJ2

[Roberto Lara @RL_OncoDrugDev]

#GoHabsGo

[Roberto Lara @RL_OncoDrugDev]

@CanadiensMTL

WE WANT THE CUP

WE WANT THE CUP

WE WANT THE CUP

WE WANT THE CUP

[Roberto Lara @RL_OncoDrugDev]

I pick the #GoHabsGo to win Game 6. Watch tonight at 8ET! #StanleyCup

[Roberto Lara @RL_OncoDrugDev]

@ChrisDoko @BiotechCH Understandable it is Sunday evening after all. Thank you for the information and for ad hoc demo of the @dealforma platform. 😎

[Roberto Lara @RL_OncoDrugDev]

@ChrisDoko I attended today’s @BiotechCH session and was left thinking about your statement on the pace of acquisitions and the “earlier” stage of development that companies are being picked up. Would you be able to kindly elaborate on that further?

[Roberto Lara @RL_OncoDrugDev]

@ChrisDoko @BiotechCH Thank you this is so cool.
One follow-up question. Any trends on who is doing the acquisitions (Top 20 Pharma or slightly larger emerging or mid-size companies)?

[Chris Dokomajilar @ChrisDoko]

@RL_OncoDrugDev @BiotechCH I left 2021 YTD out as it would look strange on the charts (low M&A volume so far). Looks similar to 2020 with 70% prior to an approved product and about 50% Phase I and earlier

[Biotech Hangout @BiotechCH]

“Watch out for drug-pricing headlines this week” - @bradloncar ending up this week’s review with a quick prediction!

[Roberto Lara @RL_OncoDrugDev]

@SahilBloom @readwiseio save thread

[Precision for Medicine @Precision4Med]

Precision's Megan Liles offers 5 actionable steps to making clinical trials more patient-centric. https://t.co/Z6w8RIRjs3

[Roberto Lara @RL_OncoDrugDev]

@BiotechCH Thank you! I am in and eager to listen in on the next session!

[Roberto Lara @RL_OncoDrugDev]

@PDRennert how do I get an invite into @BiotechCH ? thanks in advance!